IT1199180B - Riduzione degli effetti tossici cau sati da farmaci antrachinonici - Google Patents
Riduzione degli effetti tossici cau sati da farmaci antrachinoniciInfo
- Publication number
- IT1199180B IT1199180B IT48710/84A IT4871084A IT1199180B IT 1199180 B IT1199180 B IT 1199180B IT 48710/84 A IT48710/84 A IT 48710/84A IT 4871084 A IT4871084 A IT 4871084A IT 1199180 B IT1199180 B IT 1199180B
- Authority
- IT
- Italy
- Prior art keywords
- drugs
- toxic effects
- effects caused
- anthrachinonic
- reduction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT48710/84A IT1199180B (it) | 1984-08-09 | 1984-08-09 | Riduzione degli effetti tossici cau sati da farmaci antrachinonici |
US06/763,472 US4980149A (en) | 1984-08-09 | 1985-08-07 | Reduction of the toxic effects caused by anthraquinone drugs |
AT85110007T ATE55254T1 (de) | 1984-08-09 | 1985-08-08 | Verminderung der toxischen wirkungen von anthrachinon-medikamenten. |
JP60173331A JPS61171425A (ja) | 1984-08-09 | 1985-08-08 | 医薬組成物 |
EP85110007A EP0173145B1 (en) | 1984-08-09 | 1985-08-08 | Reduction of the toxic effects caused by anthraquinone drugs |
DE8585110007T DE3579074D1 (de) | 1984-08-09 | 1985-08-08 | Verminderung der toxischen wirkungen von anthrachinon-medikamenten. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT48710/84A IT1199180B (it) | 1984-08-09 | 1984-08-09 | Riduzione degli effetti tossici cau sati da farmaci antrachinonici |
Publications (3)
Publication Number | Publication Date |
---|---|
IT8448710A0 IT8448710A0 (it) | 1984-08-09 |
IT8448710A1 IT8448710A1 (it) | 1986-02-09 |
IT1199180B true IT1199180B (it) | 1988-12-30 |
Family
ID=11268179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT48710/84A IT1199180B (it) | 1984-08-09 | 1984-08-09 | Riduzione degli effetti tossici cau sati da farmaci antrachinonici |
Country Status (6)
Country | Link |
---|---|
US (1) | US4980149A (it) |
EP (1) | EP0173145B1 (it) |
JP (1) | JPS61171425A (it) |
AT (1) | ATE55254T1 (it) |
DE (1) | DE3579074D1 (it) |
IT (1) | IT1199180B (it) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2109572C (en) * | 1992-03-23 | 2004-11-09 | Kenneth Naoyuki Matsumura | Method for reducing side-effects of a drug |
US5916903A (en) * | 1997-02-28 | 1999-06-29 | Synapse Pahrmaceuticals International, Inc. | Method for reducing the effects of antineoplastic disease treatment |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3763136A (en) * | 1971-12-07 | 1973-10-02 | Diagnostic Data Inc | One step chromatographic isolation of orgotein |
JPS5632422A (en) * | 1979-08-27 | 1981-04-01 | Mochida Pharmaceut Co Ltd | Preventive and remedy for disorder caused by active oxygen in living body |
IT1142524B (it) * | 1981-05-27 | 1986-10-08 | Serono Ist Farm | Composizione farmaceutica contenente orgoteina |
JPS58158192A (ja) * | 1982-03-15 | 1983-09-20 | Ajinomoto Co Inc | 発酵法によるl−グルタミン酸の製造方法 |
US4548927A (en) * | 1983-05-25 | 1985-10-22 | Eaton John W | Method and agents for raising animal tolerance to oxidant stress-inducing antibiotics |
-
1984
- 1984-08-09 IT IT48710/84A patent/IT1199180B/it active
-
1985
- 1985-08-07 US US06/763,472 patent/US4980149A/en not_active Expired - Fee Related
- 1985-08-08 AT AT85110007T patent/ATE55254T1/de not_active IP Right Cessation
- 1985-08-08 EP EP85110007A patent/EP0173145B1/en not_active Expired - Lifetime
- 1985-08-08 JP JP60173331A patent/JPS61171425A/ja active Pending
- 1985-08-08 DE DE8585110007T patent/DE3579074D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE3579074D1 (de) | 1990-09-13 |
JPS61171425A (ja) | 1986-08-02 |
IT8448710A0 (it) | 1984-08-09 |
IT8448710A1 (it) | 1986-02-09 |
US4980149A (en) | 1990-12-25 |
EP0173145B1 (en) | 1990-08-08 |
EP0173145A3 (en) | 1986-03-19 |
ATE55254T1 (de) | 1990-08-15 |
EP0173145A2 (en) | 1986-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
ES2058420T3 (es) | Preparados farmaceuticos combinados y su utilizacion como medicamentos antineoplasicos. | |
DE69327432D1 (de) | Heilmittel für wunden und hämorrhoiden | |
AU1935788A (en) | A process for producing an administration and/or dosage form for medically active ingredients of drugs | |
PT86186A (en) | Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same | |
AR006401A1 (es) | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. | |
DE69812100T2 (de) | Adenosin enthaltendes arzneimittel | |
ES2038289T3 (es) | Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal. | |
DE69004532D1 (de) | Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen. | |
ZA877901B (en) | Active compounds for use in the treatment of tumors | |
ES2043696T3 (es) | Derivados de prostaglandina e1 (derivados-pge1) como substancias activas farmaceuticas y medicamentos que contienen estos compuestos, especialmente para aplicacion transcutanea. | |
IT1199180B (it) | Riduzione degli effetti tossici cau sati da farmaci antrachinonici | |
IL102032A0 (en) | 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
DK0521057T3 (da) | Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse | |
AU564439B2 (en) | Pharmaceutical compositions containing l-alpha- glycerylphosphorylcholine | |
ES2038621T3 (es) | Utilizacion de gangliosidos exogenos para la preparacion de un medicamento a utilizar en enfermedades tumorales como factor de proteccion contra la toxicidad por medicamentos antitumorales. | |
NO862321D0 (no) | Fysiologisk middel for oekning av transdermal avlevering av legemidler. | |
ES8801624A1 (es) | Procedimiento para preparar disulfuros heterociclicos | |
IL96161A0 (en) | Application of n-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for the treatment of coronary insufficiency | |
DE69306118D1 (de) | Onconase und cisplatin, melphalan und adriamycin enthaltende arzneimittel | |
UA19504A (uk) | Засіб для лікуваhhя гhійhих запалеhь шкіри та підшкірhої клітковиhи |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19930722 |